Developmental milestones of vertically HIV infected and seroreverters children: Follow up of 83 children

Arquivos de Neuro-Psiquiatria

Volumn 59, Issue 3 B, 2001, Pages 691-695

  Bruck, Isac ^a,b   Tahan, Tony Tannous ^a   Rodrigues Da Cruz, Cristina ^a   Martins, Luzilma Terezinha Flenik ^a   Antoniuk, Sérgio Antonio ^a   Rodrigues, Marcelo ^a   De Souza, Sílvia Mara ^a   De Bruyn, Laís Regina ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b CENEP   (Brazil)

Author keywords

Human immunodeficiency virus (HIV); Neurodevelopment delay; Neurological screening test

Indexed keywords

ARTICLE; CHILD; CHILD DEVELOPMENT; COMPUTER ASSISTED TOMOGRAPHY; DEVELOPMENTAL DISORDER; DISEASE TRANSMISSION; EPIDEMIOLOGY; FEMALE; HEARING TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; LANGUAGE DEVELOPMENT; MALE; NEUROPSYCHOLOGICAL TEST; NEWBORN; PRESCHOOL CHILD; SERODIAGNOSIS;

CHILD; CHILD DEVELOPMENT; CHILD, PRESCHOOL; DEVELOPMENTAL DISABILITIES; DISEASE TRANSMISSION, VERTICAL; EPIDEMIOLOGIC STUDIES; FEMALE; HEARING TESTS; HIV INFECTIONS; HIV SERONEGATIVITY; HUMANS; INFANT; INFANT, NEWBORN; LANGUAGE DEVELOPMENT; MALE; NEUROPSYCHOLOGICAL TESTS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0035458881     PISSN: 0004282X     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0004-282x2001000500007     Document Type: Article

References (23)

1. Belman AL. Acquired immunodeficiency syndrome and the child's central nervous system. Pediatr Clin North Am 1992;39:691-714.
2. Tardieu M. HTV-1 and the developing central nervous system. Dev Med Child Neurol 1998;40:843-846.
3. Chase C, Vibbert M, Pelton SI, Coulter DL, Cabrai H. Early neurodevelopmental growth in children with vertically transmitted human immunodeficiency virus infection. Arch Pediatr Adolesc Med 1995;149:850-855.
4. Wachtel RC, Tepper VJ, Houck D, McGrath CJ, Thompson C. Neurodevelopment in pediatric HIV infection: the use of CAT/CLAMS. Clin Pediatr 1994;33:416-420.
5. Chase C, Coulter D, Vibbert M, Woodward P, Harris M, Mitrano J. Mental and motor development in HIV-infected and seroreverter infants. In Programs and abstracts of neuroscience of HIV infection: basic clinical frontiers. Eighth International Conference on AIDS/STD World Congress. Amsterdam 1992:Abstract 34.
6. França SN. Análise clínico laboratorial dos pacientes com hipotiroidismo congênito diagnosticado pelo programa de rastreamento neonatal no Estado do Paraná: pacientes do grupo controle avaliados no període de junho a agosto de 1995. Dissertação de Mestrado, Universidade Federal do Paraná, Curitiba, 1997.
7. Frankenburg WK, Dodds JB. The Denver Developmental Screening Test. Pediatrics 1967;71:181-191.
8. Wachtel RC, Shapiro BK, Palmer BF, Allen MC, Capute AJ. CAT/CLAMS: a tool for the Pediatric Evaluation of infants and young children with developmental delay. Clin Pediatr 1994,33:410-415.
9. Capute AJ, Shapiro BK, Wachtel RC, Gunter VA, Palmer FB. The Clinical Linguistic and Auditory Milestone Scale (CLAMS). Identification of cognitive defects in motor-delayed children. AJDC 1986;140:694-698.
10. Capute AJ, Accardo PJ. The infant neurodevelopmental assessment: a clinical interpretive manual for CAT-CLAMS in the first two years of life. Part 1. Curr Probl Pediatr 1996;26:238-256.
11. Rossman MJ, Hyman SL, Rorabaugh ML, Berlin LE, Allen MC, Modlin JF. The CAT / CLAMS assessment for early intervention services. Clin Pediatr 1994;33:404-409.
12. Kube DA, Wilson WM, Petersen MC, Palmer FB. CAT / CLAMS: its use in detecting early childhood cognitive impairment. Pediatr Neurol 2000;23:208-215.
13. Nellhaus G. Head circumference from birth to eighteen years. Pediatrics 1968;41:106.
14. Tellechea N, Silva CLO, Colvero M, Schirmer M, Afonso-Galvão N. Neurosida. Rev Neurol (Barc) 1997;25:903-905.
15. Chase C, Ware J, Hittelman J, et al. Early cognitive and motor development among infants born to women infected with human immunodeficiency virus (Abstract). Pediatrics 2000;106:334.
16. Smith R, Malee K, Charutat M, et al. Timing of perinatal human immunodeficiency virus type 1 infection and rate of neurodevelopment. Pediatr Infect Dis J 2000;19: 862-871.
17. Borowitz KC, Glascoe FP. Sensitivity of the Denver Developmental Screening Test in speech and language screening. Pediatrics 1986; 78:1075-1078.
18. Meisels SJ, Margolis LH. Is the early and periodic screening, diagnosis, and treatment program effective with developmentally disabled children? Pediatrics 1988;81:262-271.
19. Meisels SJ. Can developmental screening tests identify children who are developmentally at risk? Pediatrics 1989;83:578-585.
20. Applebaum A. Validity of the revised Denver Developmental Screening Test for referred and non-referred samples. Psychol Rep 1978;43:227-233.
21. Sciarrilo WG, Brown MM, Robinson NM, Bennett FC, Sells CJ. Effectiveness of the Denver Developmental Screening Test with biologically vulnerable infants. J Dev Behav Pediatr 1986;7:77-83.
22. Greer S, Bauchner H, Zuckerman B. The Denver developmental screening test: How good is its predictive validity? Dev Med Child Neurol 1989;31:774-781.
23. De Carli C, Civitello LA Brouwers P, Pizzo PA. The prevalence of computed tomographic abnormalities of the cerebrum in 100 consecutive children symptomatic with the human immune deficiency virus. Ann Neurol 1993;34:198-205.